Search Results

The purpose of the control solution test is to validate the performance of the GlucoSure STAR & GlucoTRACK Blood Glucose Monitoring Systems using a testing solution with a known range of glucose. A control test that falls within the acceptable range indicates the user's technique is appropriate and the test strip and meter are functioning properly.

Control solution containing D-glucose as its reactive component for use as a quality control material for blood glucose monitoring systems.

The provided text describes the acceptance criteria and the study conducted for the Contrex Plus Low Control Solution. This device is a quality control material for blood glucose monitoring systems, not an AI-powered diagnostic device, so many of the requested AI/MRMC specific questions are not applicable.

Here's the information based on the provided text, with "N/A" (Not Applicable) for questions that don't fit the scope of this type of device or for which information is not provided.

Acceptance Criteria and Device Performance

Study Details

1. A table of acceptance criteria and the reported device performance: (See table above)

2. Sample sizes used for the test set and the data provenance (e.g. country of origin of the data, retrospective or prospective):

   • Control Solution Qualification: 80 test strips over 10 days (for one lot of control solution).
   • Use Life Study: 5 meters, one lot of test strips. Three lots of low control solution were tested, with 8 bottles per lot (4 for open-bottle testing, 4 for un-opened vial testing).
   • Shelf Life Study: Two lots of test strips, ten meters. Three lots of low control solution were tested. For each lot, 10 test strips were tested at each test point.
   • Data Provenance: Not explicitly stated, but the submitter is Apex BioTechnology Corp. from Hsinchu Science Park, CHINA (TAIWAN). The studies appear to be prospective, laboratory-based testing for product quality control.

3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts (e.g. radiologist with 10 years of experience):

   • N/A. This is a quality control material where "ground truth" is defined by the expected chemical concentration range of glucose in the solution, and its interaction with a device. No human expert interpretation is involved in establishing the "ground truth" of the control solution's performance.

4. Adjudication method (e.g. 2+1, 3+1, none) for the test set:

   • N/A. Adjudication methods are typically relevant for diagnostic or image-based studies where expert consensus resolves discrepancies. For a control solution, the results are quantitative measurements against predefined ranges.

5. If a multi reader multi case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance:

   • N/A. This is not an AI/imaging device.

6. If a standalone (i.e. algorithm only without human-in-the-loop performance) was done:

   • N/A. This is a control solution for a blood glucose monitoring system, not an algorithm. The "performance" is the accuracy of the glucose meter reading the control solution within its specified range.

7. The type of ground truth used (expert consensus, pathology, outcomes data, etc):

   • The "ground truth" for the control solution's performance is the assigned control solution range (40-70 mg/dL), which is presumably established through rigorous chemical analysis during the manufacturing process of the control solution itself. The conformity of the meter's reading to this known chemical range is the measure of the system's performance.

8. The sample size for the training set:

   • N/A. This is not an AI/machine learning device that requires a training set.

9. How the ground truth for the training set was established:

   • N/A. No training set is applicable.

Ask a specific question about this device